ImmunityBio, Inc. (IBRX)
USD 2.65
(-6.36%)
USD 2.65
(-6.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -366.75 Million | -337.5 Million | -274.41 Million | -171.72 Million | -152.1 Million | -63.38 Million |
| Net Income | -583.19 Million | -417.32 Million | -349.84 Million | -224.18 Million | -160.15 Million | -96.22 Million |
| Depreciation & Amortization | 18.51 Million | 18.26 Million | 14.23 Million | 12.73 Million | 14.04 Million | 9.55 Million |
| Deferred income taxes | 6.47 Million | -4000.00 | -8000.00 | -2.93 Million | -8000.00 | -498 Thousand |
| Stock-based compensation | 49.16 Million | 40.17 Million | 57.18 Million | 2.18 Million | 3.42 Million | 2.04 Million |
| Change in working capital | 3.97 Million | -8 Million | -19.11 Million | 16.36 Million | -15.63 Million | -554 Thousand |
| Other non-cash items | 138.31 Million | 29.37 Million | 23.13 Million | 24.11 Million | 6.23 Million | 44.55 Million |
| Investing Cash Flow | -30.47 Million | 27.29 Million | -84.88 Million | -19.81 Million | 18.55 Million | 57.1 Million |
| Investments in PPE | -30.58 Million | -99.39 Million | -33.56 Million | -1.66 Million | -4.28 Million | -13.1 Million |
| Acquisitions | -114 Thousand | -1 Million | 20.49 Million | 8000.00 | 200 Thousand | 412 Thousand |
| Investment purchases | -10.35 Million | -34.31 Million | -141.75 Million | -91.76 Million | -87.19 Million | -95.49 Million |
| Sales/Maturities of investments | 10.47 Million | 162 Million | 69.92 Million | 73.62 Million | 112.33 Million | 165.28 Million |
| Other Investing Activities | 114 Thousand | 105.45 Million | -51.32 Million | -8000.00 | -2.5 Million | 35.02 Million |
| Financing Cash Flow | 558.34 Million | 233.61 Million | 505.44 Million | 150.67 Million | 114.27 Million | -771 Thousand |
| Debt repayment | -451.38 Million | -58 Thousand | -338.5 Million | -3.94 Million | -2.27 Million | -477 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.44 Million | -616 Thousand | -4.06 Million | -503 Thousand | -2.5 Million | -228 Thousand |
| Common Stock Issuance | 110.39 Million | 60.42 Million | 164.53 Million | 86.3 Million | 30 Million | 57 Thousand |
| Other Financing Activities | 899.33 Million | 174.47 Million | 1.01 Billion | 73.26 Million | 91.33 Million | -123 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -6.47 Million | 8 Million | -3.71 Million | 2.57 Million | 1.18 Million | -1.1 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.45 Million | -16 Million | -15.39 Million | 13.79 Million | -16.82 Million | 546 Thousand |
| Cash at beginning of period | 104.64 Million | 181.28 Million | 35.09 Million | 75.98 Million | 95.27 Million | 23.87 Million |
| Cash at end of period | 265.45 Million | 104.96 Million | 181.28 Million | 35.09 Million | 75.98 Million | 16.82 Million |
| Capital Expenditure | -30.58 Million | -99.39 Million | -33.56 Million | -1.66 Million | -4.28 Million | -13.1 Million |
| Effect of forex changes on cash | -292 Thousand | 284 Thousand | 48 Thousand | -25 Thousand | -21 Thousand | -30 Thousand |
| Net cash flow / Change in cash | 160.81 Million | -76.31 Million | 146.18 Million | -40.88 Million | -19.29 Million | -7.05 Million |
| Free Cash Flow | -397.34 Million | -436.9 Million | -307.98 Million | -173.39 Million | -156.39 Million | -76.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -134.58 Million | -134.13 Million | -233.39 Million | -583.19 Million | -95.64 Million | -138.21 Million |
| Depreciation & Amortization | 4.4 Million | 4.55 Million | 4.56 Million | 18.51 Million | 4.58 Million | 4.68 Million |
| Deferred income taxes | - | - | -24.77 Million | 6.47 Million | -13.68 Million | 10.41 Million |
| Stock-based compensation | 9.63 Million | 8.26 Million | 12.77 Million | 49.16 Million | 14.44 Million | 11.06 Million |
| Change in working capital | 5.36 Million | -3.89 Million | -25.74 Million | 3.97 Million | -7 Million | 9.05 Million |
| Other non-cash items | 14.82 Million | 18.22 Million | 151.31 Million | 138.31 Million | 9.89 Million | 23.22 Million |
| Investing Cash Flow | -51.49 Million | -35.62 Million | 2.24 Million | -30.47 Million | -15.63 Million | -8.6 Million |
| Investments in PPE | -724 Thousand | -1.26 Million | -7.95 Million | -30.58 Million | -5.67 Million | -8.52 Million |
| Acquisitions | - | - | -10.2 Million | -114 Thousand | - | - |
| Investment purchases | -85.76 Million | -48.36 Million | -166 Thousand | -10.35 Million | -9.95 Million | -78 Thousand |
| Sales/Maturities of investments | 35 Million | 14 Million | 10.37 Million | 10.47 Million | - | - |
| Other Investing Activities | - | -34.36 Million | 10.2 Million | 114 Thousand | -9.95 Million | -78 Thousand |
| Financing Cash Flow | 148.89 Million | 10.22 Million | 200.53 Million | 558.34 Million | 237.5 Million | 43.41 Million |
| Debt repayment | -21 Thousand | -21 Thousand | -192.74 Million | -451.38 Million | -19 Thousand | -19 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -3.86 Million | -1.56 Million | -3.44 Million | -1.46 Million | -60 Thousand |
| Common Stock Issuance | 3.62 Million | 14.11 Million | 9.35 Million | 110.39 Million | 39.95 Million | 13.5 Million |
| Other Financing Activities | 145.29 Million | 10.24 Million | 383.92 Million | 899.33 Million | 200.49 Million | 30.04 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 4.65 Million | 4.31 Million | -2.87 Million | -6.47 Million | -2.73 Million | -1.53 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 708 Thousand | -8.2 Million | -22.87 Million | 10.45 Million | -4.27 Million | 10.59 Million |
| Cash at beginning of period | 133.36 Million | 265.78 Million | 177.96 Million | 104.64 Million | 43.83 Million | 88.8 Million |
| Cash at end of period | 130.43 Million | 133.36 Million | 265.45 Million | 265.45 Million | 178.29 Million | 43.83 Million |
| Capital Expenditure | -724 Thousand | -1.26 Million | -7.95 Million | -30.58 Million | -5.67 Million | -8.52 Million |
| Effect of forex changes on cash | 12 Thousand | -39 Thousand | -27 Thousand | -292 Thousand | -1000.00 | -10 Thousand |
| Net cash flow / Change in cash | -2.93 Million | -132.41 Million | 87.48 Million | 160.81 Million | 134.46 Million | -44.97 Million |
| Free Cash Flow | -101.07 Million | -108.24 Million | -123.22 Million | -397.34 Million | -93.07 Million | -88.29 Million |
NVEC
7616
JMBRF
4845
MGRM
300554